NCT02953899 Contingency Management as an Adjunct Treatment for Rural and Remote Disordered Gamblers
| NCT ID | NCT02953899 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Lethbridge |
| Condition | Gambling Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2016-11 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2016-11 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this project is to pilot contingency management as an adjunct treatment to counselling as usual using internet delivered video-conferencing applications for remote disordered gamblers. This project further investigates the impact of adding contingency management to counselling to improve counselling attendance and retention and uses internet-delivered approaches to assist rural and remote disordered gamblers gain access to counselling treatments.
Eligibility Criteria
Inclusion Criteria: * capable of providing written consent, * received a diagnosis of gambling disorder (American Psychiatric Association, 2013), * gambled within the last month, * live in a rural or remote location, and * speak English Exclusion Criteria: * Medically unmanaged psychiatric or neurological disorder(s) except for disordered gambling
Contact & Investigator
Darren R Christensen, PhD
PRINCIPAL INVESTIGATOR
University of Lethbridge
Frequently Asked Questions
Who can join the NCT02953899 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Gambling Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02953899 currently recruiting?
Yes, NCT02953899 is actively recruiting participants. Contact the research team at darren.christensen@uleth.ca for enrollment information.
Where is the NCT02953899 trial being conducted?
This trial is being conducted at Lethbridge, Canada.
Who is sponsoring the NCT02953899 clinical trial?
NCT02953899 is sponsored by University of Lethbridge. The principal investigator is Darren R Christensen, PhD at University of Lethbridge. The trial plans to enroll 54 participants.